Litigator of the Week Runners-Up And Shout Outs
Partners Daniel Laytin, Alyssa Kalisky and Katie Lencioni and associate Max Samels received a shout-out for The American Lawyer Litigation Daily's "Litigator of the Week" for their work for Eli Lilly.
"... Sticking with insulin pricing for a moment, shout out to defense lawyers for Sanofi-Aventis, Eli Lilly and Co., Novo Nordisk, and AstraZeneca who fended off an antitrust suit claiming the companies colluded to rescind a long-standing discount— the 340B Drug Pricing Program—for safety-net medical facilities that treat patients otherwise be unable to get care. Chief U.S. District Judge Elizabeth Wolford in Rochester, New York held last week that the companies’ individual 340B reforms didn’t amount to “parallel conduct” under the antitrust laws and that the lawsuit was essentially “a backdoor attempt to use the antitrust laws to enforce plaintiffs’ preferred interpretation of the 340B statute.” The defense line-up includes Daniel Laytin, Alyssa Kalisky, Katie Lencioni and Max Samels of Kirkland & Ellis and Thomas D’Antonio of Hodgson Russ for Eli Lilly; Rajeev Muttreja, Toni-Ann Citera and Aaron Healey of Jones Day and Warren Rosenbaum and Brian Capitummino of Woods Oviatt Gilman for Sanofi-Aventis; Ashley Parrish of King & Spalding and Carolyn Nussbaum of Nixon Peabody for Novo Nordisk; and C. Scott Lent and Matthew Tabas of Arnold & Porter Kaye Scholer and Kyle Gooch of Harris Beach for AstraZeneca."
